GlassScriptPhysician profile
Rahul S Thomas
NPI 1447540471
$7,924.00
in general payments reported to CMS, 2019-2025
27 companies · $2,551 in 2025
The $2,551 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $137 · 2021: $1,073 · 2022: $523 · 2023: $1,471 · 2024: $1,726 · 2025: $2,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,179 · Travel and Lodging: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,179.06 |
| Travel and Lodging | $1,568.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,335.73 | 2021-2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $1,525.42 | 2020-2025 | Versacross Access Solution, Watchman Flx, Sq-Rx Pulse Generator |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $661.82 | 2019-2025 | Lifevest |
| Medtronic, INC. | $642.21 | 2021-2025 | Micra, Linq II, Corevalve Evolut R |
| Inari Medical, INC. | $373.15 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $332.69 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Assurity, Mitraclip |
| Abiomed | $259.86 | 2023-2025 | Impella |
| Medtronic Vascular, INC. | $199.20 | 2019 | |
| Merck Sharp & Dohme LLC | $191.63 | 2021-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.80 | 2022-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $142.89 | 2021-2025 | |
| Cvrx, INC. | $129.78 | 2023 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $124.93 | 2021-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $117.46 | 2022-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $103.44 | 2021-2025 | Eliquis |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $97.16 | 2022-2024 | Indigo System |
| Cardinal Health 200 LLC | $91.78 | 2019 | |
| Cardiovascular Systems INC. | $84.12 | 2020 | |
| Sanofi-Aventis U.S. LLC | $75.73 | 2023 | |
| Pfizer INC. | $68.81 | 2019-2024 | |
| Kestra Medical Technology Services, INC. | $39.84 | 2023 | Assure Wcd |
| Scpharmaceuticals INC. | $33.66 | 2025 | |
| Livanova USA, INC. | $28.92 | 2022-2023 | Lifesparc |
| Alnylam Pharmaceuticals INC. | $28.42 | 2025 | Onpattro |
| Bard Peripheral Vascular, INC. | $23.74 | 2024 | Venclose Maven Catheter |
| Philips North America LLC | $20.10 | 2024 | (Ck4) Mcot |
| Biotronik INC. | $19.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.